Clinical Features and Integrated Care Pathway for Second Primary Malignancies after CAR-T Cell Therapy
ZHANG Hao, WU Xueting, HE Shujiao, WANG Yiran
Chinese Journal of Pharmacovigilance . 2025, (9): 1012 -1017 .  DOI: 10.19803/j.1672-8629.20250457